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1. Synthetic procedures for 1b–f  
 
General comments. The triazolium salt 1a was reported previously.S1 CH2Cl2 was dried by 
passage through solvent purification columns. All other chemicals are commercially available 
and were used as received. A Biotage Initiator 2.0 apparatus was used for microwave 
syntheses. 1H and 13C{1H} NMR spectra were recorded on Bruker spectrometers at room 
temperature, unless stated otherwise, and were referenced to external SiMe4. Chemical shifts 
(δ) are given in ppm and coupling constants J in Hz. NMR assignments are based on 
distortionless enhancement of polarization transfer (DEPT) experiments or on homo- and 
heteronuclear shift correlation spectroscopy. Elemental analyses were performed by the 
Microanalytical Laboratory of the ETH Zürich (Switzerland). Mass spectra were measured by 
electrospray ionization (ESI-MS) in MeCN on a Bruker 4.7 BioAPEX II instrument. Infrared 
spectra were recorded on Bruker tensor 27 using a Golden Gate ATR.  
 
Improved synthesis of phenyl azide.
S2 In a flask containing aniline (3 mL, 32.9 mmol) and 
MeCN (45mL) at 0°C, tBuONO (5.85 mL, 49.2 mmol) were added slowly and the solution 
was stirred 10 min at 0°C. TMSN3 (5.22 mL, 39.6 mmol) were added dropwise to the 
solution, which was stirred 3 h at 0°C followed by 48 h at rt After evaporation of MeCN, the 
residu was purified by silica column chromatography using hexane: Et3N (99:1) as eluent. A 
yellow oil was obtained after evaporation of volatiles (2.87 g, 73%). Spectroscopic data are 
identical to those reported, though some assignments have been re-evaluated. 
1H NMR (300 MHz, CDCl3, 298 K): δ 7.42-7.34 (m, 2H, Hortho), 7.20-7.15 (m, 1H, Hpara), 
7.07-7.03 (m, 2H, Hmeta); 13C{1H} NMR (75 MHz, CDCl3, 298 K): δ 140.1 (Cipso) 129.9 
(Cortho), 125.0 (Cpara), 119.1 (Cmeta). 
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Method A. To a solution of NaN3 (4 equiv) in H2O, tBuOH was added followed by the alkyl 
halide (1 equiv). After stirring at rt for 48 h, copper wire (0.8 equiv.), alkyne (1.2 equiv.) and 
an aqueous solution of CuSO4 (1 M, 0.2 equiv.) were added. The obtained solution was then 
irradiated in a microwave reactor at 100°C using high absorption. Subsequently, an aqueous 
solution of NH4OH was added and the solution was extracted with CH2Cl2. The combined 
organic phases were washed with H2O and brine and dried over Na2SO4 before all volatiles 
were evaporated under reduced pressure. After dissolution of the residue in acetone, the 
solution was filtered through Celite and evaporated to dryness to provide the corresponding 
triazole. A high pressure flask was subsequently charged with this triazole in MeCN and an 
excess of MeI and was heated to 60°C for the time indicated. After evaporation of MeCN, the 
residue was purified by precipitation and, if specified, by column chromatography. 
 
Method B. To a solution of phenylazide (1 equiv.) in H2O and tBuOH (1:1), alkyne (1.3 
equiv.), sodium ascorbic acid (0.4 equiv.) and CuSO4 (0.2 equiv.) were added. After stirring 
the reaction during the time indicated, the solution was treated in the same way as described 
in method A. 
 
Synthesis of 1b. According to method A, NaN3 (1.58 g, 24.3 mmol) in H2O (8 mL), tBuOH 
(8 mL), EtI (0.48 mL, 5.9 mmol), freshly condensed butyne (5 mL, 62.3 mmol), copper wire 
(0.3 g, 4.7 mmol), CuSO4 solution (1 M, 1.2 mL, 1.2 mmol) were reacted in the microwave 
reactor for 30 min. After purification, 1,4-diethyl triazole was obtained as a pale yellow liquid 
(0.49 g, 65%). 1H NMR (360 MHz, CDCl3, 298 K): δ 7.24 (s, 1H, Htrz), 4.28 (q, 3JHH = 7.3 
Hz, 2H, NCH2CH3), 2.65 (q, 3JHH = 7.6 Hz, 2H, CCH2CH3), 1.44 (t, 3JHH = 7.3 Hz, 3H, 
NCH2CH3), 1.18 (t, 3JHH = 7.6 Hz, 3H, CCH2CH3); 13C{1H} NMR (90 MHz, CDCl3, 298 K): 
δ 149.7 (Ctrz), 119.5 (CHtrz), 45.0 (NCH2CH3), 19.0 (CCH2CH3), 15.5 (NCH2CH3), 13.6 
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(CCH2CH3); Anal. Found (calcd) for C6H11N3 × 1/25 CH3COCH3 (125.17): C 57.64 (57.65), 
H 8.64 (8.89), N 32.73 (32.96). 
1,4-diethyl triazole (1.15 g, 9.2 mmol) dissolved in MeCN (25 mL) and MeI (3.5 mL, 56.2 
mmol) was heated in a high-pressure flask to 60 °C during 3 d. After evaporation, the residue 
was purified by column chromatography with a gradient eluent CH2Cl2/Et2O, CH2Cl2/acetone 
to afford 1b (2.2 g, 89%). 1H NMR (500 MHz, CDCl3, 298 K): δ 9.16 (s, 1H, Htrz), 4.75 (q, 
3JHH = 7.3 Hz, 2H, NCH2CH3), 4.29 (s, 3H, NCH3), 2.99 (q, 3JHH = 7.5 Hz, 2H, CCH2CH3), 
1.67 (t, 3JHH = 7.3 Hz, 3H, NCH2CH3), 1.43 (t, 3JHH = 7.5 Hz, 3H, CCH2CH3); 13C{1H} NMR 
(125 MHz, CDCl3, 298 K): δ 145.9 (Ctrz), 129.1 (CHtrz), 49.9 (NCH2CH3), 38.8 (NCH3), 18 
(CCH2CH3), 14.9 (NCH2CH3), 11.7 (CCH2CH3); HR-MS (ESI): m/z 140.11838 (calc. for 
C7H14N3
+ 140.11822). 
 
Synthesis of 1c. According to method A, NaN3 (1.04 g, 16 mmol) in H2O (8 mL), tBuOH (8 
mL), BuI (0.46 mL, 4 mmol), hexyne (0.51 mL, 4.4 mmol), Cu(0) (0.2 g, 3.1 mmol), CuSO4 
solution (0.8 mL, 0.8 mmol) were reacted  in the microwave reactor for 1.5 h. Purification 
afforded 1,4-dibutyl triazole as a pale yellow oil (0.46 g, 63%). 1H NMR (360 MHz, CDCl3, 
298 K): δ 7.20 (s, 1H, Htrz), 4.20 (t, 3JHH = 7.3 Hz, 2H, NCH2CH2CH2CH3), 2.59 (t, 3JHH = 7.7 
Hz, 2H, CCH2CH2CH2CH3), 1.75 (quint, 3JHH = 7.3 Hz. 2H, NCH2CH2CH2CH3), 1.54 (quint, 
3JHH = 7.7 Hz, 2H, CCH2CH2CH2CH3), 1.32-1.18 (m, 4H, CCH2CH2CH2CH3, 
NCH2CH2CH2CH3), 0.85-0.79 (m, 6H, CCH2CH2CH2CH3, NCH2CH2CH2CH3); 13C{1H} 
NMR (90 MHz, CDCl3, 298 K): δ 148.1 (Ctrz), 120.4 (CHtrz), 49.7 (NCH2CH2CH2CH3), 32.2 
(NCH2CH2CH2CH3), 31.5 (CCH2CH2CH2CH3), 25.2 (CCH2CH2CH2CH3), 22.2 
(CCH2CH2CH2CH3), 19.6 (NCH2CH2CH2CH3), 13.7 (CCH2CH2CH2CH3), 13.3 
(NCH2CH2CH2CH3) ; Anal. Found (calcd) for C6H11N3 × 0.5 H2O (181.28): C 62.91 (63.12), 
H 10.41 (10.59), N 21.70 (22.08).  
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The triazole  (0.98 g, 5.4 mmol) dissolved in MeCN (30 mL) and MeI (1 mL, 16 mmol) was 
stirred in a high-pressure flask to 60 °C for 2.5 d. All MeCN was evaporated and the residue 
was three times dissolved in acetone (8 mL) and precipitated with pentane (90 mL). After 
column chromatography (eluted with CH2Cl2 first then with acetone), triazolium salt 1c was 
obtained as a yellow oil (1.19 g, 68%). 1H NMR (500 MHz, CDCl3, 298 K): δ 9.0 (s, 1H, 
Htrz), 4.60 (t, 
3JHH = 7.4 Hz, 2H, NCH2CH2CH2CH3), 4.2 (s, 3H, NCH3), 2.85 (t, 3JHH = 7.7 
Hz, 2H, CCH2CH2CH2CH3), 1.90 (quint, 3JHH = 7.4 Hz, 2H, NCH2CH2CH2CH3), 1.67 (quint, 
3JHH = 7.7 Hz, 2H, CCH2CH2CH2CH3), 1.36 (sext, 3JHH = 7.7 Hz, 2H, CCH2CH2CH2CH3), 
1.30 (sext, 3JHH = 7.4 Hz, 2H, NCH2CH2CH2CH3), 0.87-0.82 (m, 6H, CCH2CH2CH2CH3, 
NCH2CH2CH2CH3); 13C{1H} NMR (125 MHz, CDCl3, 298 K): δ 144.4 (Ctrz), 129 (CHtrz), 
53.7 (NCH2CH2CH2CH3), 38.8 (NCH3), 31.1 (NCH2CH2CH2CH3), 28.8 (CCH2CH2CH2CH3), 
23.5 (CCH2CH2CH2CH3), 21.9 (CCH2CH2CH2CH3), 19.2 (NCH2CH2CH2CH3), 13.4, 13.2 
(CCH2CH2CH2CH3 + NCH2CH2CH2CH3); HR-MS (ESI): m/z 196.18096 (calc. for C11H22N3+ 
196.180824. 
 
Synthesis of 1d. According to method A, NaN3 (1.04 g, 16 mmol) in H2O (8 mL), tBuOH (8 
mL), BuI (0.46 mL, 4 mmol), phenylacetylene (0.53 mL, 4.8 mmol), Cu(0) (0.21 g, 3.4 
mmol), CuSO4 solution (0.8 mL, 0.8 mmol) were reacted in the microwave reactor for 1.5 h. 
After purification, 1-butyl-4-phenyl triazole was isolated as a yellow oil (0.55 g, 69%). 1H 
NMR (360 MHz, CDCl3, 298 K): δ 7.82 (d, 3JHH = 7.3 Hz, 2H, Horthoph), 7.74 (s, 1H, Htrz), 
7.42 (t, 3JHH = 7.3 Hz, 2H, Hmetaph), 7.32 (d, 3JHH = 7.3 Hz, 1H, Hparaph), 4.38 (t, 3JHH = 7.4 Hz, 
2H, NCH2CH2CH2CH3), 1.92 (quint., 3JHH = 7.4 Hz, 2H, CCH2CH2CH2CH3), 1.38 (sext., 3JHH 
= 7.4 Hz, 2H, NCH2CH2CH2CH3), 0.96 (t, 3JHH = 7.4 Hz, 3H, NCH2CH2CH2CH3); 13C{1H} 
NMR (90 MHz, CDCl3, 298 K): δ 147.8 (Ctrz), 130.8 (Cipsoph), 128.9 (Cmetaph), 128.1 (Cparaph), 
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125.8 (Corthpph), 119.5 (CHtrz), 50.2 (NCH2CH2CH2CH3), 32.4 (NCH2CH2CH2CH3), 19.8 
(NCH2CH2CH2CH3), 13.6 (NCH2CH2CH2CH3). 
This triazole (0.64 g, 3.2 mmol) in MeCN (15 mL) was heated with MeI (1.2 mL, 19.3 mmol) 
to 60 °C during 3 d. After evaporation, the residue was three times dissolved in CHCl3 (5 mL) 
and precipitated with Et2O (90 mL), followed by gradient column chromatography using 
Et2O, CH2Cl2, and finally acetone as eluents to afford 1d as a yellow oil (0.70 g, 65%). 
1H 
NMR (500 MHz, CDCl3, 298 K): δ 9.42 (s, 1H, Htrz), 7.72-7.70 (m, 2H, Horthoph), 7.54-7.47 
(m, 3H, Hmetaph, H
para
ph), 4.74 (t, 
3JHH = 7.5 Hz, 2H, NCH2CH2CH2CH3), 4.29 (s, 3H, NCH3), 
2.02 (quint., 3JHH = 7.5 Hz, 2H, NCH2CH2CH2CH3), 1.39 (sext., 3JHH = 7.5 Hz, 2H, 
NCH2CH2CH2CH3), 0.91 (t, 3JHH = 7.5 Hz, 3H, NCH2CH2CH2CH3); 13C{1H} NMR (125 
MHz, CDCl3, 298 K): δ 142.9 (Ctrz), 131.9 (Cph), 130.5 (Cph), 129.7, 129.6 (Cph + CHtrz), 
121.7 (Cipsoph), 54.2 (NCH2CH2CH2CH3), 39.5 (NCH3), 31.2 (NCH2CH2CH2CH3), 19.4 
(NCH2CH2CH2CH3), 13.4 (NCH2CH2CH2CH3); HR-MS (ESI): m/z 216.14926 (calc. for 
C13H18N3
+ 216.14952). 
 
Synthesis of 1e. According to method B, PhN3 (0.64 g, 5.4 mmol) in H2O/tBuOH (1:1) (20 
mL), hexyne (0.74 mL, 6.4 mmol), CuSO4 (0.17 g, 1.1 mmol), sodium ascorbic acid (0.43 g, 
2.2 mmol) were added and stirred at rt during 48 h. After purification, 1-phenyl-4-butyl 
triazole was obtained as a dark yellow oil (0.72 g, 66%). The NMR data differ from those 
published previously,S3 and are thus reported here: 1H NMR (360 MHz, CDCl3, 298 K): δ 
7.71 (s, 1H, Htrz), 7.66 (d, 
3JHH = 7.7 Hz, 2H, Horthoph), 7.45 (t, 3JHH = 7.7 Hz, 2H, Hmetaph), 
7.36-7.31 (m, 1H, Hparaph), 2.74 (t, 
3JHH = 7.7 Hz, 2H, NCH2CH2CH2CH3), 1.66 (quint., 3JHH = 
7.7 Hz, 2H, NCH2CH2CH2CH3), 1.37 (sext., 3JHH = 7.4 Hz, 2H, NCH2CH2CH2CH3), 0.90 (t, 
3JHH = 7.4 Hz, 3H, NCH2CH2CH2CH3); 13C{1H} NMR (90 MHz, CDCl3, 298 K): δ 149.1 
(Ctrz), 137.2 (C
ipso
ph), 129.6 (C
meta
ph),  128.3 (C
para
ph), 120.2 (C
ortho
ph), 118.8 (CHtrz), 31.5 
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(CH2CH2CH2CH3), 25.3 (CH2CH2CH2CH3), 22.3 (CH2CH2CH2CH3), 13.8 
(CCH2CH2CH2CH3). 
After heating of a solution of 1-phenyl-4-butyl triazole (0.71 g, 3.5 mmol) in MeCN (20 mL) 
and MeI (2 mL, 32.1 mmol) at 60°C for 20 h, all volatiles were removed under reduced 
pressure. The residue was twice dissolved in CH2Cl2 (10 mL) and precipitated with Et2O (90 
mL). The yellow powder was washed with acetone (15 mL). After evaporation of all volatiles 
1e was isolated as analytically pure pale yellow powder (1.0 g, 92%). 1H NMR (300 MHz, 
CDCl3, 298 K): δ 9.55 (s, 1H, Htrz), 8.08-8.02 (m, 2H, Horthoph), 7.62-7.57 (m, 3H, Hmetaph, 
Hparaph), 3.07 (t, 
3JHH = 7.8 Hz, 2H, CH2CH2CH2CH3), 1.86 (quint., 3JHH = 7.8 Hz, 2H, 
CH2CH2CH2CH3), 1.46 (sext., 3JHH = 7.4 Hz, 2H, CH2CH2CH2CH3), 0.96 (t, 3JHH = 7.4 Hz, 
3H, CH2CH2CH2CH3); 13C{1H} NMR (75 MHz, CDCl3, 298 K): δ 146.3 (Ctrz), 134.8 
(Cipsoph), 132.0 (C
para
ph),130.5 (C
meta
ph), 127.6 (CHtrz), 121.7 (C
ortho
ph), 39.4 NCH3, 29.4 
(CH2CH2CH2CH3), 24.1 (CH2CH2CH2CH3), 22.4 (CH2CH2CH2CH3), 13.8 
(CCH2CH2CH2CH3); Anal. Found (calcd) for C13H18IN3 (343.21): C 45.71 (45.49), H 5.24 
(5.29), N 12.13 (12.24). 
 
Synthesis of 1f. According to method B, PhN3 1 (0.45 g, 3.8 mmol) in H2O/tBuOH (1:1) (30 
mL), phenylacetylene (0.54 mL, 4.9 mmol), CuSO4 (0.13 g, 0.8 mmol), sodium ascorbic acid 
(0.3 g, 0.4 mmol) were added and stirred at rt during 48 h. After treatment, 1,4-diphenyl 
triazole was isolated as a pale yellow powder (0.75 g, 89%). Spectroscopic data are in 
agreement with those published previously.S2 
In a high-pressure flask, 1,4-diphenyl triazole (1.89 g, 8.6 mmol) dissolved in MeCN (30 mL) 
and MeI (3.5 mL, 56.2 mmol) was stirred at 60°C during 4 d. After precipitation of an acetone 
solution with Et2O, a pale yellow powder was obtained (2.7 g, 86%). 
1H NMR (500 MHz, 
CDCl3, 298 K): δ 9.74 (s, 1H, Htrz), 8.16-8.14 (m, 2H, HorthoNph), 8.96-8.94 (m, 2H, HorthoCph), 
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7.59-7.56 (m, 3H, HmetaNph, H
para
Nph), 7.51-7.48 (m, 3H, H
meta
Cph H
para
Cph), 4.44 (s, 1H, NCH3); 
13C{1H} NMR (125 MHz, CDCl3, 298 K): δ 144.1 (Ctrz), 134.6 (CipsoNPh), 132 (CparaCPh), 
131.9 (CparaNPh), 130.3 (C
meta
NPh), 130 (C
ortho
CPh), 129.6 (C
meta
CPh), 127.2 (CtrzH), 121.9 
(CorthoNPh), 121.3 (C
ipso
Cph), 40.1 (NCH3); Anal. Found (calcd) for C15H14IN3 (363.19): C 
49.37 (49.60), H 4.02 (3.89), N 11.56 (11.57). 
 
 
2. Spectroscopic data for 4a at the slow exchange limit 
 
Table S1.
 1H NMR chemical shifts (500 MHz, CD3CN, 253 K) of the isomers of complex 4a 
a 
 Horthoar NCH2 NCH3 NCH2CH3 
52% isomer  8.20 (7.3 Hz) 4.81 (7.3 Hz) 4.04 1.67 (7.3 Hz) 
32% isomer 8.00 (6.8 Hz) 5.00 (7.3 Hz) 3.99 1.83 (7.3 Hz) 
11% isomer 8.13 (7.3 Hz) 4.75 (7.3 Hz) 4.02 1.64 (7.3 Hz) 
5% isomer 7.94 (7.0 Hz) 4.93 (7.3 Hz) 3.98 1.78 (7.3 Hz) 
a values in ppm, 3JHH values in parentheses; multiplicities for Horthoar (d), NCH2 (q), NCH2CH3 
(t), Hmetaar and H
para
ar appear as a multiplet (7.65–7.47) that could not be resolved for the 
different isomers. 
 
 
3. Spectroscopic data for [Rh(triazolylidene)Cl(CO)2] 7b–f 
 
Synthetic aspects. A flask containing complex 6 in CH2Cl2 was saturated with gaseous CO 
by bubbling for 20 min. The volatiles were subsequently evaporated at rt under high vaccuum 
and the residue was washed with pentane to give complex 7 as a yellowish residue in 
essentially quantitative yield. The spectroscopic data of 7a were published previously.S1 
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Spectroscopic data for 7b. 
1H NMR (400 MHz, CD2Cl2, 298 K): δ 4.62 (q, 3JHH = 7.3 Hz, 
2H, NCH2CH3), 3.99 (s, 3H, NCH3), 2.87 (q, 3JHH = 7.6 Hz, 2H, CCH2CH3), 1.60 (t, 3JHH = 
7.3 Hz, 3H, NCH2CH3), 1.35 (t, 3JHH = 7.6 Hz, 3H, CCH2CH3); 13C{1H} NMR (100 MHz, 
CD2Cl2, 298 K): δ 186.8 (d, 1JCRh = 53.4 Hz, CO), 184.3 (d, 1JCRh = 74.6 Hz, CO), 159.8 (d, 
1JCRh = 38.8 Hz, C-Rh), 148.2 (d, 2JCRh = 2.2 Hz, Ctrz), 51.0 (NCH2CH3), 36.5 (NCH3), 19.3 
(CCH2CH3), 15.8 (NCH2CH3), 14.1 (CCH2CH3); IR (CH2Cl2): 2065 cm–1, 1983 cm–1 (νCO). 
 
Spectroscopic data for 7c. 
1H NMR (300 MHz, CD2Cl2, 298 K): δ 4.56 (t, 3JHH = 7.4 Hz, 
2H, NCH2CH2CH2CH3), 3.98 (s, 1H, NCH3), 2.83 (t, 3JHH = 7.8 Hz, 2H, CCH2CH2CH2CH3), 
2.06 (quint., 3JHH = 7.4 Hz, 2H, NCH2CH2CH2CH3), 1.76 (quint., 3JHH = 7.8 Hz, 2H, 
CCH2CH2CH2CH3), 1.52-1.32 (m, 4H, CCH2CH2CH2CH3 NCH2CH2CH2CH3), 1.01-0.95 (m, 
6H, CCH2CH2CH2CH3, NCH2CH2CH2CH3); 13C{1H} NMR (75 MHz, CD2Cl2, 298 K): δ 
187.0 (d, 1JCRh = 53.4 Hz, CO), 184.4 (d, 1JCRh = 74.8 Hz, CO), 160.4 (d, 1JCRh = 39.1 Hz, C-
Rh), 147.2 (d, 2JCRh = 2.8 Hz, Ctrz), 55.4 (NCH2CH2CH2CH3), 36.6 (NCH3), 32.5 
(NCH2CH2CH2CH3), 31.9 (CCH2CH2CH2CH3), 25.7 (CCH2CH2CH2CH3), 23.0 
(CCH2CH2CH2CH3), 20.2 (NCH2CH2CH2CH3), 14.0, 13.9 (CCH2CH2CH2CH3, 
NCH2CH2CH2CH3); IR (CH2Cl2): 2065 cm–1, 1983 cm–1 (νCO).  
 
Spectroscopic data for 7d. 1H NMR (400 MHz, CD2Cl2, 298 K): δ 7.76-7.71 (m, 2H, 
Horthoph), 7.59-7.53 (m, 3H, H
meta
ph, H
para
ph), 4.71 (t, 
3JHH = 7.4 Hz, 2H, NCH2CH2CH2CH3), 
4.04 (s, 3H, NCH3), 2.14 (quint., 
3JHH = 7.4 Hz, 2H, NCH2CH2CH2CH3), 1.45 (sext., 3JHH = 
7.4 Hz, 2H NCH2CH2CH2CH3), 1.01 (t, 3JHH = 7.4 Hz, 3H, NCH2CH2CH2CH3); 13C{1H} 
NMR (100 MHz, CD2Cl2, 298 K): δ 186.8 (d, 1JCRh = 54.2 Hz, CO), 183.9 (d, 1JCRh = 75.4 
Hz, CO), 161.3 (d, 1JCRh = 38.8 Hz, C-Rh), 146.8 (d, 2JCRh = 2.2 Hz, Ctrz), 130.8 (Corthoph), 
 - S10 - 
130.5 (Cparaph), 129.3 (C
meta
ph), 127.9 (C
ipso
ph), 55.1 (NCH2CH2CH2CH3), 37.9 (NCH3), 32.5 
(NCH2CH2CH2CH3), 20.2 (NCH2CH2CH2CH3), 13.9 (NCH2CH2CH2CH3); IR (CH2Cl2): 
2065 cm–1, 1983 cm–1 (νCO). 
 
Spectroscopic data for 7e. 1H NMR (400 MHz, CD2Cl2, 298 K): δ 8.15-8.09 (m, 2H, 
Horthoph), 7.58-7.54 (m, 3H, H
meta
ph, H
para
ph), 4.12 (s, 3H, NCH3), 3.00 (t, 
3JHH = 7.8 Hz, 2H, 
CH2CH2CH2CH3), 1.84 (quint., 3JHH = 7.8 Hz, 2H, CH2CH2CH2CH3), 1.49 (sext., 3JHH = 7.4 
Hz, 2H, CH2CH2CH2CH3), 1.01 (t, 3JHH = 7.4 Hz, 3H, CH2CH2CH2CH3); 13C{1H} NMR (100 
MHz, CD2Cl2, 298 K): δ 186.7 (d, 1JCRh = 54.9 Hz, CO), 183.8 (d, 1JCRh = 75.4 Hz, CO),  
161.8  (d, 1JCRh = 39.5 Hz, C-Rh), 148.3 (d, 2JCRh = 1.5 Hz, Ctrz), 140.2 (Cipsoph), 130.6 
(Cparaph), 129.6 (C
meta
ph), 125.2 (C
ortho
ph), 37.0 (NCH3), 31.8 (CH2CH2CH2CH3), 25.7 
(CH2CH2CH2CH3), 23.1 (CH2CH2CH2CH3), 14.1 (CH2CH2CH2CH3); IR (CH2Cl2): 2065 cm–
1, 1983 cm–1 (νCO). 
 
Spectroscopic data for 7f: 1H NMR (400 MHz, CD2Cl2, 298 K): δ 8.24-8.20 (m, 2H, 
HorthoNph), 7.85-7.81 (m, 2H, H
ortho
Cph), 7.61-7.57(m, 6H, H
meta
Cph, H
para
Cph, H
meta
Nph H
para
Nph), 
4.15 (s, 1H, NCH3); 
13C{1H} NMR (100 MHz, CD2Cl2, 298 K): δ 186.7 (d, 1JCRh = 54.8 Hz, 
CO), 183.7 (d, 1JCRh = 74.6 Hz, CO), 162.6 (d, 1JCRh = 39.5 Hz, C-Rh), 147.5 (d, 2JCRh = 2.2 
Hz, Ctrz), 140.2 (C
ipso
ph), 131.1 (C
ortho
ph), 130.8 (C
para
ph), 130.7 (C
meta
ph), 129.6 (C
ipso
ph), 129.4 
(Cmetaph), 127.7 (C
ortho
ph), 125.3, 38.2 (NCH3); IR (CH2Cl2): 2068cm
–1, 1988 cm–1 (νCO). 
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4. Crystallographic supplementary information 
 
Supplementary information for 3a 
A pseudo-polymorph of cis–3a was formed upon crystallization of the complex from CH2Cl2 
and pentane. This pseudo-polymorph comprises a co-crystallized molecule of CH2Cl2. Bond 
lengths and angles deviate slightly more than 3σ as compared to the solvent-free structure of 
cis–3a, though the principle features are identical (e.g., larger I1–Pd1–I2 angle than C1–Pd1–
C12, approximate 80° tilting of the N-heterocycle with respect to the palladium coordination 
plane). 
 
 
Fig. S1. ORTEP representation of the polymorph cis–3a × CH2Cl2. (50% probability, 
hydrogens, disorder in the position of the CH3 group of one ethyl substituent, C22, and in the 
CH2Cl2 molecule omitted for clarity). Selected bond lengths (Å) and angles(°):C1–Pd1 
1.992(6), C12–Pd1 1.985(6), I1–Pd1 2.6567(6), I2–Pd1 2.6630(6), C1–Pd1–C12 85.7(2), C1–
Pd1–I1 173.39(15), C1–Pd1–I2 90.62(15), C12–Pd1–I1 87.92(17), C12–Pd1–I2 176.08(17), 
I1–Pd1–I2 95.781(19). 
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Supplementary information for 5e 
 
Fig. S2. Illustration of the different geometries of dimeric complexes of 5e, demonstrating an 
open-book configuration (top-left; distorted tetrahedral Pd2I2 arrangement) and a planar 
configuration (bottom right, distorted square plane of Pd2I2 unit). 
 
Supplementary information for 5f 
 
Fig. S3. ORTEP representation of one of the two independent molecules of 5f comprising a 
cyclometalated N-phenyl substituent. In both molecules, only the N-bound phenyl group is 
cyclometalated, no signs for C–H bond activation in the C-bound phenyl substituent were 
obtained. Both dimeric complexes exhibit an essentially co-planar arrangement of the 
cyclometalating ligands, the open-book-type distortion is much less pronounced as compared 
to 5e. 
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Structure determination and refinement of the complexes.  
Suitable single crystals were mounted on a Stoe Image Plate Diffraction System equipped 
with a graphite monochromator and data collection was performed using Mo-Kα radiation (λ = 
0.71073 Å), except for the crystal of 4a, which was measured on a SuperNova A 
diffractometer using Cu-Kα radiation (λ = 1.54184 Å). All structures were solved by direct 
methods using the program SHELXS-97 and refined by full matrix least-squares on F2 with 
SHELXL-97.S4 All hydrogen atoms were included in calculated positions and treated as riding 
atoms using the SHELXL-97 default parameters. All non hydrogen atoms were refined 
anisotropically. A semi-empirical absorption correction was applied using MULscanABS for 
2a, 2c, 2e, trans-3a, cis-3a, and cis-3a × CH2Cl2, and an empirical absorption correction was 
applied using DELrefABS for 2b, 2d, both implemented in PLATON03.S5 An analytical 
absorption correction was applied for 4a.S6 A numerical absorption correction was applied to 
5e and 5f using STOE X-Red & X-Shape.S7 
Complex 2a crystallized with two independent centrosymmetric binuclear complexes and 
one disordered molecule of CH2Cl2 in the unit cell. One iodide in one molecule is disordered 
over two positions (occupancy of I3A/I3B is 0.7/0.3). The CH3 of the ethyl substituents are 
disordered over two positions in each molecule (occupancies 0.7/0.3). Various restraints were 
applied, including the phenyl rings in both molecules which were fitted to regular hexagons 
using the EADP and DFIX instructions. The SQUEEZE routine in PLATON was used to treat 
disordered solvent.S5 The potential voids were calculated to contain 115 electrons for a 
volume of 338.6 Å3 and were attributed to disordered CH2Cl2.  
The crystal of 2b was a twin, therefore a twin-integration has been performed taking into 
account the two parts of the twin. The data set of the major component of the twin has been 
used for structure solution.  
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In the crystal of cis-3a × CH2Cl2, the CH3 group of one ethyl substituent and the CH2Cl2 
molecule were disordered. 
Crystals of 5f contained volatile solvent and therefore cooling was necessary throughout the 
mounting procedure in order to afford a sufficiently diffracting specimen. During the 
refinement, not all solvent molecules could be resolved due to disorder and were thus 
removed by the SQUEEZE routine in PLATON.S5 Samples of 5e showed twinning. Two 
domains were indexed and integrated using STOE X-Area.S7 Structure solution and initial 
refinement was carried out on the basis of non-overlapping reflections, belonging to one 
domain only. The resulting model was further refined to convergence in SHELXL-97 with a 
HKLF5 dataset (featuring both domains including overlapping reflections). A free-format CIF 
using the LIST 6 command was written and imported in WinGX.S8 Final HKLF4 refinement 
was carried out. This procedure allows to merge the reflections of the major component and to 
obtain averaged standard deviations. Further crystallographic details on all complexes are 
compiled in Table S2. 
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Table S2. Crystallographic data for all complexes. 
 2a 2b 2c 2d 2e trans-3a  cis-3a 
CCDC number 800720 800721 800722 800724 800723 800725 800726 
Color, shape red block yellow needle orange plate  yellow plate orange plate yellow rod pale yellow plate 
crystal size/mm 0.16 × 0.22 × 0.45 0.50 × 0.11 × 0.05 0.20 × 0.35 × 0.40 0.20 × 0.18 × 0.13 0.40 × 0.30 × 0.15 0.15 × 0.15 × 0.45 0.15 × 0.15 × 0.10 
empirical formula C22H26I4N6Pd2 
× 0.5 CH2Cl2 
C14H26I4N6Pd2 C22H42I4N6Pd2 C26H34I4N6Pd2 
× 2 CH2Cl2 
C26H34I4N6Pd2 
× CH2Cl2 
C22H26I2N6Pd C22H26I2N6Pd 
Fw 1137.35 998.81 1111.06 1320.84 1235.92 734.69 734.69 
T/K 173 173(2) 173 173(2) 173(2) 173 173 
cryst syst triclinic monoclinic triclinic triclinic monoclinic monoclinic monoclinic 
space group P–1 (No. 2) P21/n (No. 14) P–1 (No. 2) P–1 (No. 2) P21/c (No. 14) P21/c (No. 14) P21/c (No. 14) 
unit cell         
   a/Å 11.6395(8) 7.6739(15) 8.2840(8) 9.9204(14) 8.7187(5) 9.6971(7) 9.5874(7) 
   b/Å 13.1766(10) 14.442(2) 9.6916(9) 10.5994(13) 15.5227(7) 13.6009(12) 13.4276(9) 
   c/Å 13.3345(9) 11.515(3) 11.8468(11) 10.5337(14) 14.8293(9) 9.4707(8) 19.6702(14) 
   α/deg 71.430(5) 90 71.804(11) 91.475 90 90 90 
   β/deg 66.276(5) 92.469(17) 80.644(11) 94.257 96.836(5) 105.490(6) 102.350(8) 
   γ/deg 70.827(6) 90 69.299(11) 112.019 90 90 90 
   V/Å3 1726.9(2) 1275.0(5) 843.77(16) 1022.3(2) 1992.70(19) 1203.71 2473.7(3) 
Z 2 2 1 1 8 2 4 
Dcalc/g cm-3 2.106 2.602 2.187 2.146 2.060 2.027 1.973 
µ/mm-1 (Mo Kα) 4.715 6.264 4.745 4.188 4.160 3.357 3.268 
no. of total, unique reflns 16880, 6105 9417, 2254 6731, 3090 7810, 3523 25123, 3747 10308, 2268 12387, 4790 
Rint 0.042 0.2046 0.036 0.1113 0.0316 0.052 0.054 
transmn range 0.238–0.475 0.028–0.410 0.205–0.384 0.308–0.576 0.543–0.899 0.3014–0.5997 0.334–0.613 
no. paras, restr. 275, 7 70, 0 154, 0 200, 0 199, 0 145, 0 285, 0 
R,a Rw,b 0.0319, 0.0849 0.0836, 0.2110 0.0313, 0.0823 0.0887, 0.2291 0.0291, 0.0972 0.0256, 0.0648 0.0366, 0.0892 
GOF 1.02 0.837 0.938 0.996 1.129 0.98 0.91 
min/max resid density/e Å-3 -1.00, 0.84 -1.472, 1.068 -1.25, 1.22 -2.569, 1.504 -0.788, 1.373 -0.85, 0.59 -1.65, 0.95 
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Table S2 (continued). Crystallographic data for complexes. 
 cis-3a × CH2Cl2 4a 5e 5f 
CCDC number 800727 800728 800729 800730 
Color, shape yellow needle yellow block yellow needle yellow, block 
Crystal size/mm 0.50 × 0.20 × 0.15 0.27 × 0.17 × 0.17 0.5 × 0.2 × 0.07 0.4 × 0.3 × 0.2 
Empirical formula C22H26I2N6Pd × CH2Cl2 C22H26Cl2N6Pd C13H16IN3Pd C15H12I2N3Pd × 2/3 CH2Cl2 
Fw /g mol-1 819.61 554.79 447.59 524.19 
T/K 173 100 100 100 
Crystal system monoclinic triclinic triclinic monoclinic 
Space group P21/c (No. 14) P–1 (No. 2) P–1 (No. 2) P21/n (No. 14) 
unit cell     
   a/Å 12.7461(9) 8.2661(2) 12.4522(11) 15.4702(14) 
   b/Å 17.2912(9) 8.8875(3) 12.7285(11) 20.6531(10) 
   c/Å 14.1530(10) 9.3445(3) 15.3977(14) 16.2193(10) 
   α/deg 90 108.081(3) 73.253(7) 90.00 
   β/deg 112.592(5) 115.551(3) 66.849(7) 91.153(6) 
   γ/deg 90 81.735(2) 87.828(7) 90.00 
   V/Å3 2879.9(3) 577.89(3) 2140.9(3) 5181.1(6) 
Z 4 1 6 12 
Dcalc/g cm-3 1.890 1.586 2.083 2.016 
µ/mm-1 (Mo Kα) 2.997 8.776 3.449 3.067 
no. of total, unique reflns 28970, 5134 8246, 2401 42691, 7982 35537, 9049 
Rint 0.0892 0.0436 n/a
c 0.1104 
Transmission range 0.369–0.520 0.215–0.419 0.182–0.472 0.398–0.644 
no. paras, restraints 318, 6 145, 0 493, 0 598, 0 
R,a Rw,b 0.0396, 0.0945 0.0421, 0.1139 0.0627, 0.1734 0.0630, 0.1385 
GOF 0.91 1.061 1.068 0.949 
min/max resid density/e Å-3 -1.087, 0.880 –1.618, 1.716 -2.099, 1.117 -1.241, 1.634 
a
 R1 = Σ||FO|–|FC||/Σ|FO| for all I > 2σ(I);   b wR2 = [Σw(FO2–FC2)2/Σ(w(FO4)]1/2;   c hklf5 refinement  
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